Global Expansion Primex is expanding in paediatric pharmaceuticals with a growing partner network across over 40 countries and a strong EU manufacturing base, presenting opportunities to broaden market access and distribution partnerships in new regions.

Oral Paediatric Solution The approval of a novel oral solution for paediatric sedation indicates a growing niche in pediatric anesthesia that can be leveraged to cross-sell related analgesics, local anaesthetics, and dental products under the OGNA brand to hospitals and pediatric clinics.

Strategic Hires Recent appointment of a Head of Business Development signals a capability to accelerate market penetration, channel development, and strategic deals—a good entry point for joint business planning with distributors and hospital partners.

EU Manufacturing All products are manufactured in Europe with a Swiss headquarters, suggesting reliability and compliance advantages for European procurement teams and potential for contract manufacturing opportunities or private-label collaborations with regional players.

Strong Revenue Growth Proven underlying operations and historical revenue growth, coupled with partnerships and conference engagements in major markets, create openings for phased account targeting—focusing on hospitals, academic centers, and procurement bodies seeking innovative anesthesia solutions.